Literature DB >> 9073052

Primary radiotherapy of T1 and T2 glottic carcinoma--analysis of treatment results and prognostic factors in 223 patients.

C Klintenberg1, J Lundgren, G Adell, M Tytor, L Norberg-Spaak, R Edelman, J M Carstensen.   

Abstract

Treatment results in 223 patients with T1 and T2 glottic carcinoma were analysed. A multivariate analysis was performed to evaluate the prognostic significance of factors related to tumour, patient and treatment. Locoregional control after radiotherapy was 90% for 129 patients with T1 tumours and 73% for 94 with T2 tumours. Disease-specific survival was 96% and 81% for patients with T1 and T2 tumours, respectively. In the multivariate analysis of locoregional control, subglottic extension contributed prognostic information to T-stage. In the univariate analysis, number of involved tumour sites, cord mobility and treatment interruption had a significant influence, which was lost in the multivariate analysis. Age gave additional prognostic information in the multivariate analysis of disease-specific survival. Significant adverse effects of radiotherapy were found in 9 patients (4%). Forty-nine patients (22%) had a second malignancy, 11 (5%) diagnosed before the glottic carcinoma.

Entities:  

Mesh:

Year:  1996        PMID: 9073052     DOI: 10.3109/02841869609098524

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  3 in total

1.  Radiotherapy for head and neck cancer.

Authors:  Shyh-An Yeh
Journal:  Semin Plast Surg       Date:  2010-05       Impact factor: 2.314

2.  Bcl-2 expression predicts radiotherapy failure in laryngeal cancer.

Authors:  P Nix; L Cawkwell; H Patmore; J Greenman; N Stafford
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

3.  Voice and Functional Outcomes of Transoral Laser Microsurgery for Early Glottic Cancer: Ventricular Fold Resection as a Surrogate.

Authors:  Ilyes Berania; Christophe Dagenais; Sami P Moubayed; Tareck Ayad; Marie-Jo Olivier; Louis Guertin; Eric Bissada; Jean-Claude Tabet; Apostolos Christopoulos
Journal:  J Clin Med Res       Date:  2015-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.